Hmmm, how much Tempol sales is ADMP currently bringing in related to treating Covid? Let me answer, specific to treating Covid, answer is $0, so if they split that ADMP is left with $0.
We are betting on them actually producing sales and big sales at that. So if we get to the point where they are raking in $$$$$ and the share price is up, up and away, then we can compare, but not really b/c one is vaccine and one is a POTENTIAL treatment, to the Pfizer agreement (excerpt below).
'The COVID-19 vaccine BNT162b2, developed by Pfizer and BioNTech (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year. Even with the company splitting profits with BioNTech, Pfizer should conservatively make in the ballpark of $17 billion from BNT162b2 this year.'
News 
Market Data 
Discover 
